Concepedia

Yoshihito Morimoto

YM

Statistics

Publications

3

Citations

55

H-Index

3

Active since

2009

Affiliations

Kitasato Institute Hospital(Current)

Showa Pharmaceutical University

Yoshihito Morimoto is an author at Kitasato Institute Hospital specializing in oncology, pancreatic cancer, and pharmacology.

ORCID

Publications per year

2009–2020

3

Publications

3

Experimental study of combination therapy with S-1 against pancreatic cancer

Jun Yoshizawa, Asako Takizawa, Osamu Takeuchi et al. · Cancer Chemotherapy and Pharmacology · 2009 · 19 citations

, , +13

Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2

Yoshihito Morimoto, Kimihiko Takada, Osamu Takeuchi et al. · Molecular and Cellular Biochemistry · 2020 · 19 citations

, , +15

Prexasertib increases the sensitivity of pancreatic cancer cells to gemcitabine and S‑1

Yoshihito Morimoto, Kimihiko Takada, Osamu Takeuchi et al. · Oncology Reports · 2019 · 17 citations · Full text

, , +10

1–3 of 3